Mel J. Yeates
Articles by Mel J. Yeates
| 4 min read
Microcombs could be used in many ways, including detecting disease and finding new planets
| 3 min read
Data on HOOKIPA’s cancer therapeutics have been published in Cell Reports Medicine
| 2 min read
The Quinten Group spins off Quinten Health, using AI for precision care and real-world data science
| 3 min read
Weill Neurohub joins forces with Genentech and Roche on neuroscience and CNS disorders
| 3 min read
Topline data from a recent Eli Lilly clinical trial indicate that tirzepatide led to superior A1C and body weight reductions from baseline compared to injectable semaglutide in adults with type 2 diabetes.
| 2 min read
EMA grants Orphan Drug designation to JR-171 for the treatment of mucopolysaccharidosis type I
| 3 min read
New biomarkers can predict risk of patients dying from bacteremia
| 4 min read
Highlights of some of the most recent new R&D tools to curb the pandemic
| 4 min read
The anti-CD117 antibody is being evaluated as a conditioning agent prior to blood stem cell transplantation
| 3 min read
Amicus’ engineered hGLA showed greater substrate reduction than wildtype hGLA
| 3 min read
Two leading scientists call on health agencies to invest in broadly effective vaccines
| 3 min read
BetterLife enters research agreement with UCSD for TD-0148A behavioral pharmacology studies
| 4 min read
High tumor mutation burden can predict immunotherapy response only in subset of cancers
| 3 min read
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
| 3 min read
Selexis and BITT enter agreement to advance BITT’s TNFR2 antagonist antibody therapy
Page 1 of 39 - 574 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
